Guinea-Bissau Dares to Prioritize Sovereignty Over Western 'Philanthropy'
📰 THE STORY: Mainstream outlets report that Guinea-Bissau has suspended a controversial US-funded hepatitis B vaccine study, citing ethical concerns and 'sovereignty.' This comes despite US health officials insisting the study by Danish researchers was still on. 🔍 WHAT THEY'RE NOT TELLING YOU: Historical Context: This is not an isolated incident. In 1996, Pfizer conducted a clinical trial for an
experimental meningitis drug, Trovan, during an epidemic in Nigeria without informed consent, leading to hundreds of children developing severe side effects, paralysis, and death. Pfizer settled for $75 million years later, but the damage was done. The pattern of Western pharmaceutical companies using African nations for ethically dubious trials is well-documented, from the Tuskegee syphilis
experiment (1932-1972) on Black men in the US to countless unconsented trials abroad. Double Standard: Imagine a developing nation proposing a 'controversial' drug trial on a vulnerable population in a Western country, say, Denmark, pushing back against US insistence. The outcry would be deafening, framed as a human rights violation and an attack on national sovereignty. Yet, when Western powers
conduct such studies in the Global South, it's often framed as 'humanitarian aid' or 'scientific progress,' with criticism dismissed as 'anti-science' or 'anti-progress.' Follow the Money: These studies, while ostensibly for health, often serve the interests of multi-billion dollar pharmaceutical companies and research institutions based in wealthy nations. The US National Institutes of Health